Valiant Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories has received a Show-Cause Notice dated September 29, 2025 from the CGST & Central Excise department in Navi Mumbai. The notice relates to the alleged wrong availment of Input Tax Credit (ITC) on capital goods during GST returns scrutiny for the financial year April 2021 to March 2022. The tax authority has proposed disallowance of ITC of ₹64.37 lakhs along with penalty, aggregating to approximately ₹70.81 lakhs. The notice has been issued under Section 73 of the CGST Act, 2017 read with Section 122. The company has stated that the matter is under consideration and it is evaluating appropriate representations to respond to the notice.
This is a preliminary tax notice and not a final order, so the impact is limited at this stage. However, if the disallowance is upheld after representation, the company could face an outflow of up to around ₹70.81 lakhs including penalty. For shareholders, this is a minor financial exposure relative to typical company operations, but it introduces some near-term uncertainty until the matter is resolved.